Rank | Gene Set | Z-score |
---|---|---|
1 | actin-mediated cell contraction (GO:0070252) | 7.67707692 |
2 | actin filament-based movement (GO:0030048) | 5.66139722 |
3 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.35934912 |
4 | creatine metabolic process (GO:0006600) | 4.95906646 |
5 | cardiac muscle hypertrophy (GO:0003300) | 4.77579754 |
6 | response to inactivity (GO:0014854) | 4.62745036 |
7 | actomyosin structure organization (GO:0031032) | 4.60559800 |
8 | striated muscle hypertrophy (GO:0014897) | 4.56644706 |
9 | neuronal action potential propagation (GO:0019227) | 4.49838593 |
10 | muscle contraction (GO:0006936) | 4.48727899 |
11 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.47692586 |
12 | synaptic vesicle exocytosis (GO:0016079) | 4.43893656 |
13 | vocalization behavior (GO:0071625) | 4.43066015 |
14 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.38145843 |
15 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.31661211 |
16 | regulation of striated muscle contraction (GO:0006942) | 4.29713836 |
17 | response to muscle activity (GO:0014850) | 4.28159546 |
18 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.27233262 |
19 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.20486245 |
20 | synaptic vesicle maturation (GO:0016188) | 4.14106324 |
21 | skeletal muscle adaptation (GO:0043501) | 4.11997178 |
22 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.10012416 |
23 | regulation of cell communication by electrical coupling (GO:0010649) | 4.07427692 |
24 | muscle system process (GO:0003012) | 4.05554841 |
25 | neuron cell-cell adhesion (GO:0007158) | 4.04892531 |
26 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.04569272 |
27 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.01189748 |
28 | heart process (GO:0003015) | 3.96984493 |
29 | heart contraction (GO:0060047) | 3.96984493 |
30 | muscle hypertrophy (GO:0014896) | 3.94610510 |
31 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.92203739 |
32 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.90954395 |
33 | skeletal muscle fiber development (GO:0048741) | 3.90680247 |
34 | NADH metabolic process (GO:0006734) | 3.85205816 |
35 | muscle fiber development (GO:0048747) | 3.79816368 |
36 | regulation of synaptic vesicle transport (GO:1902803) | 3.79756363 |
37 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.78610687 |
38 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.78610687 |
39 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.77535524 |
40 | glutamate secretion (GO:0014047) | 3.77339842 |
41 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.76468128 |
42 | myotube cell development (GO:0014904) | 3.76150460 |
43 | regulation of synapse structural plasticity (GO:0051823) | 3.74037901 |
44 | locomotory exploration behavior (GO:0035641) | 3.71323147 |
45 | protein localization to synapse (GO:0035418) | 3.68761139 |
46 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.68523878 |
47 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.65333579 |
48 | striated muscle adaptation (GO:0014888) | 3.65163982 |
49 | glycogen catabolic process (GO:0005980) | 3.65059387 |
50 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.64689018 |
51 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.64640616 |
52 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.64505149 |
53 | muscle cell cellular homeostasis (GO:0046716) | 3.59839722 |
54 | muscle tissue morphogenesis (GO:0060415) | 3.59104645 |
55 | relaxation of muscle (GO:0090075) | 3.56892644 |
56 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.55699762 |
57 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.53683275 |
58 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.51930168 |
59 | regulation of the force of heart contraction (GO:0002026) | 3.50394447 |
60 | adult heart development (GO:0007512) | 3.50323209 |
61 | positive regulation of cation channel activity (GO:2001259) | 3.49409188 |
62 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.48127526 |
63 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.47880248 |
64 | detection of calcium ion (GO:0005513) | 3.47427210 |
65 | actin-myosin filament sliding (GO:0033275) | 3.45912800 |
66 | muscle filament sliding (GO:0030049) | 3.45912800 |
67 | neurotransmitter secretion (GO:0007269) | 3.44638953 |
68 | regulation of relaxation of muscle (GO:1901077) | 3.43652448 |
69 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.43140943 |
70 | relaxation of cardiac muscle (GO:0055119) | 3.42186392 |
71 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.40532888 |
72 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.38395055 |
73 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.38395055 |
74 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.36992278 |
75 | regulation of membrane repolarization (GO:0060306) | 3.36713767 |
76 | cellular potassium ion homeostasis (GO:0030007) | 3.36520490 |
77 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.35510612 |
78 | glucan catabolic process (GO:0009251) | 3.34961963 |
79 | cardiac muscle cell development (GO:0055013) | 3.34690589 |
80 | membrane depolarization during action potential (GO:0086010) | 3.34619996 |
81 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.34314144 |
82 | muscle hypertrophy in response to stress (GO:0003299) | 3.34314144 |
83 | cardiac muscle adaptation (GO:0014887) | 3.34314144 |
84 | sarcomere organization (GO:0045214) | 3.26383240 |
85 | neuron-neuron synaptic transmission (GO:0007270) | 3.24955497 |
86 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.23321735 |
87 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.23320359 |
88 | cell communication by electrical coupling (GO:0010644) | 3.22244345 |
89 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.22111066 |
90 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.21655835 |
91 | activation of protein kinase A activity (GO:0034199) | 3.20735290 |
92 | regulation of ATP catabolic process (GO:1903289) | 3.19898329 |
93 | regulation of ATPase activity (GO:0043462) | 3.19898329 |
94 | glutamate receptor signaling pathway (GO:0007215) | 3.17197524 |
95 | glucan biosynthetic process (GO:0009250) | 3.16918607 |
96 | glycogen biosynthetic process (GO:0005978) | 3.16918607 |
97 | cardiac muscle contraction (GO:0060048) | 3.15134324 |
98 | potassium ion import (GO:0010107) | 3.14258598 |
99 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.11748961 |
100 | regulation of sarcomere organization (GO:0060297) | 3.11732277 |
101 | regulation of skeletal muscle contraction (GO:0014819) | 3.11279352 |
102 | striated muscle cell development (GO:0055002) | 3.10841562 |
103 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.10838231 |
104 | skeletal muscle tissue development (GO:0007519) | 3.10103210 |
105 | synaptic transmission, glutamatergic (GO:0035249) | 3.09316998 |
106 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.09153791 |
107 | exploration behavior (GO:0035640) | 3.09029507 |
108 | tricarboxylic acid cycle (GO:0006099) | 3.08517512 |
109 | cellular polysaccharide catabolic process (GO:0044247) | 3.07843514 |
110 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.06957032 |
111 | striated muscle contraction (GO:0006941) | 3.06115973 |
112 | cardiac cell development (GO:0055006) | 3.05368607 |
113 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.04025164 |
114 | plasma membrane repair (GO:0001778) | 3.04010177 |
115 | regulation of muscle system process (GO:0090257) | 3.02746480 |
116 | regulation of cofactor metabolic process (GO:0051193) | 3.01872009 |
117 | regulation of coenzyme metabolic process (GO:0051196) | 3.01872009 |
118 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.01523502 |
119 | regulation of actin filament-based movement (GO:1903115) | 3.00425925 |
120 | cardiac muscle cell action potential (GO:0086001) | 2.99615880 |
121 | neuromuscular process controlling posture (GO:0050884) | 2.98877192 |
122 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.98455183 |
123 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.98021873 |
124 | positive regulation of synapse maturation (GO:0090129) | 2.97698076 |
125 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.96905429 |
126 | neuron recognition (GO:0008038) | 2.95178964 |
127 | skeletal muscle contraction (GO:0003009) | 2.94430554 |
128 | regulation of cardiac muscle contraction (GO:0055117) | 2.94168629 |
129 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.93347039 |
130 | negative regulation of potassium ion transport (GO:0043267) | 2.91734387 |
131 | myofibril assembly (GO:0030239) | 2.91522258 |
132 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.91355428 |
133 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.90528745 |
134 | neurotransmitter transport (GO:0006836) | 2.90490058 |
135 | regulation of muscle contraction (GO:0006937) | 2.90137558 |
136 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 2.88943856 |
137 | sodium ion export (GO:0071436) | 2.88241060 |
138 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.87886124 |
139 | synaptic vesicle endocytosis (GO:0048488) | 2.87084539 |
140 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.87074079 |
141 | regulation of cation channel activity (GO:2001257) | 2.86376007 |
142 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.86099621 |
143 | cell communication involved in cardiac conduction (GO:0086065) | 2.83059458 |
144 | response to pheromone (GO:0019236) | 2.82657802 |
145 | long-term memory (GO:0007616) | 2.82568093 |
146 | neuromuscular synaptic transmission (GO:0007274) | 2.81874696 |
147 | positive regulation of potassium ion transport (GO:0043268) | 2.81463916 |
148 | postsynaptic membrane organization (GO:0001941) | 2.80754815 |
149 | membrane depolarization (GO:0051899) | 2.80447489 |
150 | regulation of postsynaptic membrane potential (GO:0060078) | 2.78897182 |
151 | cardiac myofibril assembly (GO:0055003) | 2.78300506 |
152 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.78048810 |
153 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.78048810 |
154 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.77112731 |
155 | gamma-aminobutyric acid transport (GO:0015812) | 2.76780692 |
156 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.75950890 |
157 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.75593168 |
158 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.74069984 |
159 | negative regulation of protein localization to cell surface (GO:2000009) | 2.73196553 |
160 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.72981677 |
161 | ATP synthesis coupled proton transport (GO:0015986) | 2.72981677 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.43765827 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.73056605 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11213147 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.99043241 |
5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.98694824 |
6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.86455061 |
7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65324799 |
8 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.55512220 |
9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.50528317 |
10 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.49828606 |
11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47664330 |
12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.46106997 |
13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.45893590 |
14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.45893590 |
15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.42130576 |
16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42007678 |
17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.41506502 |
18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.40184100 |
19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.38132588 |
20 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.33665318 |
21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.26841217 |
22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19049116 |
23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.18741525 |
24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17509050 |
25 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.14711634 |
26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.13329871 |
27 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.02379513 |
28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.97340831 |
29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.95015164 |
30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.93261978 |
31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.89577650 |
32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88036580 |
33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77998575 |
34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.76826299 |
35 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.75982669 |
36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70774386 |
37 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.62825168 |
38 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.62825168 |
39 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.62106843 |
40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.61786463 |
41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.60338130 |
42 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.56938688 |
43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.53897475 |
44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53066917 |
45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51566881 |
46 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.49625767 |
47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.44746498 |
48 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.43932778 |
49 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.42502433 |
50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39614359 |
51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39241975 |
52 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38438687 |
53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33910953 |
54 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.33657055 |
55 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.33339704 |
56 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.29626488 |
57 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.29011367 |
58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.28644286 |
59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28432443 |
60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27587740 |
61 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23957959 |
62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23634325 |
63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23474300 |
64 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22641635 |
65 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22293194 |
66 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21483241 |
67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20977134 |
68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.20793539 |
69 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19702924 |
70 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.19503294 |
71 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19451092 |
72 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.19378496 |
73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.18555776 |
74 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15595307 |
75 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.14891747 |
76 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.14641198 |
77 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14523714 |
78 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14262299 |
79 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.13293841 |
80 | AR_19668381_ChIP-Seq_PC3_Human | 1.13098686 |
81 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12228371 |
82 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.11655451 |
83 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10657255 |
84 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10562147 |
85 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.09930201 |
86 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08903349 |
87 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07623980 |
88 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.06580775 |
89 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06072967 |
90 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.05892469 |
91 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05802543 |
92 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05296307 |
93 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.05291187 |
94 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05015523 |
95 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04026259 |
96 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.03476270 |
97 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03305899 |
98 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.02785066 |
99 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02752847 |
100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01859878 |
101 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00393991 |
102 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99343038 |
103 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99162979 |
104 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99053350 |
105 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98583472 |
106 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97347967 |
107 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94318100 |
108 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93908590 |
109 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93878715 |
110 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93143044 |
111 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.93024527 |
112 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92229744 |
113 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.91976235 |
114 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.91571156 |
115 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90413969 |
116 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89227124 |
117 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89112695 |
118 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88207516 |
119 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87754792 |
120 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87555365 |
121 | FUS_26573619_Chip-Seq_HEK293_Human | 0.87188613 |
122 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.86252448 |
123 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85064614 |
124 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84964256 |
125 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.83684849 |
126 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.83684849 |
127 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.83625095 |
128 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82690049 |
129 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82611689 |
130 | JUN_21703547_ChIP-Seq_K562_Human | 0.81950073 |
131 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80420328 |
132 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80341930 |
133 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.77730690 |
134 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.77478133 |
135 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77048347 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 4.52414249 |
2 | MP0003880_abnormal_central_pattern | 3.98504020 |
3 | MP0002837_dystrophic_cardiac_calcinosis | 3.84919625 |
4 | MP0000751_myopathy | 3.52251120 |
5 | MP0003646_muscle_fatigue | 3.37590164 |
6 | MP0003635_abnormal_synaptic_transmissio | 3.14721875 |
7 | MP0004270_analgesia | 3.00075081 |
8 | MP0004145_abnormal_muscle_electrophysio | 2.95452577 |
9 | MP0009745_abnormal_behavioral_response | 2.67738442 |
10 | MP0000749_muscle_degeneration | 2.56824478 |
11 | * MP0002064_seizures | 2.54912338 |
12 | MP0009046_muscle_twitch | 2.52980271 |
13 | MP0002063_abnormal_learning/memory/cond | 2.50829852 |
14 | MP0004036_abnormal_muscle_relaxation | 2.47041475 |
15 | MP0001968_abnormal_touch/_nociception | 2.38664269 |
16 | MP0004215_abnormal_myocardial_fiber | 2.37513681 |
17 | MP0002272_abnormal_nervous_system | 2.25895308 |
18 | MP0004084_abnormal_cardiac_muscle | 2.15895829 |
19 | MP0002572_abnormal_emotion/affect_behav | 2.15067451 |
20 | MP0005451_abnormal_body_composition | 2.13523625 |
21 | MP0002822_catalepsy | 2.08696217 |
22 | MP0002734_abnormal_mechanical_nocicepti | 2.07085831 |
23 | MP0001529_abnormal_vocalization | 2.00967356 |
24 | MP0006276_abnormal_autonomic_nervous | 1.96868905 |
25 | MP0002735_abnormal_chemical_nociception | 1.96390530 |
26 | MP0005423_abnormal_somatic_nervous | 1.94766295 |
27 | MP0001486_abnormal_startle_reflex | 1.92695853 |
28 | MP0002736_abnormal_nociception_after | 1.83632150 |
29 | MP0001440_abnormal_grooming_behavior | 1.81681225 |
30 | MP0000747_muscle_weakness | 1.78281774 |
31 | MP0002067_abnormal_sensory_capabilities | 1.77432418 |
32 | MP0008569_lethality_at_weaning | 1.72749559 |
33 | MP0001501_abnormal_sleep_pattern | 1.71689527 |
34 | MP0002106_abnormal_muscle_physiology | 1.70786538 |
35 | MP0005620_abnormal_muscle_contractility | 1.68925226 |
36 | MP0001970_abnormal_pain_threshold | 1.65606806 |
37 | MP0003137_abnormal_impulse_conducting | 1.65013751 |
38 | MP0002733_abnormal_thermal_nociception | 1.61852357 |
39 | MP0004142_abnormal_muscle_tone | 1.58890567 |
40 | MP0005386_behavior/neurological_phenoty | 1.57073970 |
41 | MP0004924_abnormal_behavior | 1.57073970 |
42 | MP0003122_maternal_imprinting | 1.55451292 |
43 | MP0004130_abnormal_muscle_cell | 1.55171937 |
44 | MP0003329_amyloid_beta_deposits | 1.54668219 |
45 | MP0004233_abnormal_muscle_weight | 1.53772123 |
46 | MP0005330_cardiomyopathy | 1.53089464 |
47 | MP0005646_abnormal_pituitary_gland | 1.52101874 |
48 | MP0002909_abnormal_adrenal_gland | 1.51154930 |
49 | MP0004087_abnormal_muscle_fiber | 1.47895789 |
50 | MP0002127_abnormal_cardiovascular_syste | 1.47556280 |
51 | MP0000759_abnormal_skeletal_muscle | 1.45490710 |
52 | MP0004484_altered_response_of | 1.45406187 |
53 | MP0005369_muscle_phenotype | 1.44511972 |
54 | MP0010630_abnormal_cardiac_muscle | 1.44506964 |
55 | MP0002972_abnormal_cardiac_muscle | 1.44326420 |
56 | MP0005645_abnormal_hypothalamus_physiol | 1.41490382 |
57 | MP0004085_abnormal_heartbeat | 1.38839224 |
58 | MP0002184_abnormal_innervation | 1.37301315 |
59 | MP0001905_abnormal_dopamine_level | 1.37179971 |
60 | MP0002269_muscular_atrophy | 1.35532574 |
61 | MP0002108_abnormal_muscle_morphology | 1.34818398 |
62 | MP0009780_abnormal_chondrocyte_physiolo | 1.32495807 |
63 | MP0004811_abnormal_neuron_physiology | 1.29187541 |
64 | MP0002557_abnormal_social/conspecific_i | 1.27894296 |
65 | MP0000733_abnormal_muscle_development | 1.26053224 |
66 | * MP0002066_abnormal_motor_capabilities/c | 1.22667242 |
67 | MP0000013_abnormal_adipose_tissue | 1.22458849 |
68 | MP0000778_abnormal_nervous_system | 1.21662662 |
69 | MP0004043_abnormal_pH_regulation | 1.20426573 |
70 | MP0001984_abnormal_olfaction | 1.19786715 |
71 | MP0002332_abnormal_exercise_endurance | 1.13652441 |
72 | MP0000955_abnormal_spinal_cord | 1.09667677 |
73 | MP0003633_abnormal_nervous_system | 1.09036077 |
74 | MP0001502_abnormal_circadian_rhythm | 1.08990954 |
75 | MP0005266_abnormal_metabolism | 1.08919571 |
76 | MP0002882_abnormal_neuron_morphology | 1.07420254 |
77 | MP0003879_abnormal_hair_cell | 1.06391283 |
78 | MP0003950_abnormal_plasma_membrane | 1.06183435 |
79 | MP0000750_abnormal_muscle_regeneration | 1.04260200 |
80 | MP0004858_abnormal_nervous_system | 1.03761285 |
81 | * MP0006036_abnormal_mitochondrial_physio | 0.99940369 |
82 | MP0008775_abnormal_heart_ventricle | 0.96600664 |
83 | MP0002638_abnormal_pupillary_reflex | 0.95965427 |
84 | MP0002229_neurodegeneration | 0.95861404 |
85 | MP0004510_myositis | 0.94614842 |
86 | MP0006035_abnormal_mitochondrial_morpho | 0.93193764 |
87 | MP0003787_abnormal_imprinting | 0.89223103 |
88 | MP0003631_nervous_system_phenotype | 0.88177202 |
89 | MP0001544_abnormal_cardiovascular_syste | 0.86431823 |
90 | MP0005385_cardiovascular_system_phenoty | 0.86431823 |
91 | MP0005670_abnormal_white_adipose | 0.85600005 |
92 | MP0005535_abnormal_body_temperature | 0.85551736 |
93 | * MP0000920_abnormal_myelination | 0.84545356 |
94 | MP0005551_abnormal_eye_electrophysiolog | 0.80049777 |
95 | MP0002971_abnormal_brown_adipose | 0.74699500 |
96 | MP0003634_abnormal_glial_cell | 0.74272589 |
97 | MP0001299_abnormal_eye_distance/ | 0.72596015 |
98 | MP0000372_irregular_coat_pigmentation | 0.72340688 |
99 | MP0006138_congestive_heart_failure | 0.72194639 |
100 | MP0001661_extended_life_span | 0.72159110 |
101 | MP0004885_abnormal_endolymph | 0.71914581 |
102 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71814617 |
103 | MP0010386_abnormal_urinary_bladder | 0.70728168 |
104 | MP0008874_decreased_physiological_sensi | 0.70235490 |
105 | MP0002069_abnormal_eating/drinking_beha | 0.69866430 |
106 | MP0003183_abnormal_peptide_metabolism | 0.69580040 |
107 | MP0004742_abnormal_vestibular_system | 0.67218308 |
108 | * MP0002152_abnormal_brain_morphology | 0.66882362 |
109 | MP0008961_abnormal_basal_metabolism | 0.65767751 |
110 | MP0005666_abnormal_adipose_tissue | 0.65167729 |
111 | MP0001188_hyperpigmentation | 0.64687671 |
112 | MP0003828_pulmonary_edema | 0.64675161 |
113 | MP0004147_increased_porphyrin_level | 0.63396185 |
114 | MP0000230_abnormal_systemic_arterial | 0.59934757 |
115 | MP0003045_fibrosis | 0.59077077 |
116 | MP0000266_abnormal_heart_morphology | 0.55883295 |
117 | MP0005187_abnormal_penis_morphology | 0.55095512 |
118 | MP0005375_adipose_tissue_phenotype | 0.52672210 |
119 | MP0001986_abnormal_taste_sensitivity | 0.50712215 |
120 | MP0000003_abnormal_adipose_tissue | 0.50046636 |
121 | MP0001943_abnormal_respiration | 0.45680767 |
122 | MP0006072_abnormal_retinal_apoptosis | 0.44078022 |
123 | MP0002234_abnormal_pharynx_morphology | 0.41201076 |
124 | MP0004134_abnormal_chest_morphology | 0.40893732 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 5.78936844 |
2 | Exercise-induced myalgia (HP:0003738) | 5.38576140 |
3 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.91594171 |
4 | Calf muscle hypertrophy (HP:0008981) | 4.66488676 |
5 | Exercise-induced muscle cramps (HP:0003710) | 4.59655940 |
6 | Rhabdomyolysis (HP:0003201) | 4.27082253 |
7 | Myokymia (HP:0002411) | 4.16946171 |
8 | Sudden death (HP:0001699) | 4.09350680 |
9 | Visual hallucinations (HP:0002367) | 3.90308174 |
10 | Focal seizures (HP:0007359) | 3.87517911 |
11 | Muscle fiber inclusion bodies (HP:0100299) | 3.81413572 |
12 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.75669346 |
13 | Round ear (HP:0100830) | 3.68432090 |
14 | Atonic seizures (HP:0010819) | 3.64069038 |
15 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.62972198 |
16 | Abnormality of the calf musculature (HP:0001430) | 3.56476685 |
17 | Epileptic encephalopathy (HP:0200134) | 3.47286317 |
18 | Febrile seizures (HP:0002373) | 3.46311047 |
19 | Frequent falls (HP:0002359) | 3.44672730 |
20 | Pheochromocytoma (HP:0002666) | 3.43169809 |
21 | Myotonia (HP:0002486) | 3.42433262 |
22 | Muscle fiber splitting (HP:0003555) | 3.41848315 |
23 | Nemaline bodies (HP:0003798) | 3.34443748 |
24 | Ulnar deviation of the wrist (HP:0003049) | 3.31391218 |
25 | Absence seizures (HP:0002121) | 3.23501846 |
26 | EMG: neuropathic changes (HP:0003445) | 3.19874038 |
27 | EMG: myopathic abnormalities (HP:0003458) | 3.17860308 |
28 | Neuroendocrine neoplasm (HP:0100634) | 3.13521168 |
29 | Calcaneovalgus deformity (HP:0001848) | 3.11054337 |
30 | Difficulty running (HP:0009046) | 3.06456957 |
31 | Absent phalangeal crease (HP:0006109) | 3.03993357 |
32 | Dialeptic seizures (HP:0011146) | 3.00703023 |
33 | Increased connective tissue (HP:0009025) | 3.00241761 |
34 | Dilated cardiomyopathy (HP:0001644) | 2.99932564 |
35 | Distal lower limb muscle weakness (HP:0009053) | 2.98875267 |
36 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.97435758 |
37 | Generalized tonic-clonic seizures (HP:0002069) | 2.96559292 |
38 | Myoglobinuria (HP:0002913) | 2.95971487 |
39 | Atrial fibrillation (HP:0005110) | 2.90523078 |
40 | Acute necrotizing encephalopathy (HP:0006965) | 2.89480348 |
41 | Broad-based gait (HP:0002136) | 2.87357939 |
42 | Primary atrial arrhythmia (HP:0001692) | 2.85414022 |
43 | Hyporeflexia of lower limbs (HP:0002600) | 2.85304184 |
44 | Lipoatrophy (HP:0100578) | 2.82230540 |
45 | Deformed tarsal bones (HP:0008119) | 2.81814479 |
46 | Prolonged QT interval (HP:0001657) | 2.79094151 |
47 | Supraventricular tachycardia (HP:0004755) | 2.74670218 |
48 | Bundle branch block (HP:0011710) | 2.73988848 |
49 | Areflexia of lower limbs (HP:0002522) | 2.72183575 |
50 | Syncope (HP:0001279) | 2.69817026 |
51 | Ventricular fibrillation (HP:0001663) | 2.69539098 |
52 | Ankle clonus (HP:0011448) | 2.67707826 |
53 | Progressive cerebellar ataxia (HP:0002073) | 2.67626239 |
54 | Supraventricular arrhythmia (HP:0005115) | 2.63624607 |
55 | Abnormal EKG (HP:0003115) | 2.63454742 |
56 | Abnormal finger flexion creases (HP:0006143) | 2.59304394 |
57 | Muscle stiffness (HP:0003552) | 2.58088713 |
58 | Hyperventilation (HP:0002883) | 2.52634871 |
59 | Progressive macrocephaly (HP:0004481) | 2.52250021 |
60 | Limb-girdle muscle atrophy (HP:0003797) | 2.51370971 |
61 | Abnormal atrioventricular conduction (HP:0005150) | 2.50701041 |
62 | Generalized muscle weakness (HP:0003324) | 2.49941389 |
63 | Abnormality of the foot musculature (HP:0001436) | 2.49607003 |
64 | Truncal ataxia (HP:0002078) | 2.49044267 |
65 | Myopathic facies (HP:0002058) | 2.47647763 |
66 | Mitochondrial inheritance (HP:0001427) | 2.46121924 |
67 | Type 1 muscle fiber predominance (HP:0003803) | 2.45890048 |
68 | Distal arthrogryposis (HP:0005684) | 2.45702121 |
69 | Anxiety (HP:0000739) | 2.43296458 |
70 | Supranuclear gaze palsy (HP:0000605) | 2.40633631 |
71 | Urinary urgency (HP:0000012) | 2.39864836 |
72 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.38743633 |
73 | Depression (HP:0000716) | 2.36893392 |
74 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.36875038 |
75 | Rimmed vacuoles (HP:0003805) | 2.33342787 |
76 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.32315433 |
77 | Subaortic stenosis (HP:0001682) | 2.32315433 |
78 | Progressive inability to walk (HP:0002505) | 2.31938697 |
79 | Distal lower limb amyotrophy (HP:0008944) | 2.30851639 |
80 | Scapular winging (HP:0003691) | 2.29685877 |
81 | Hepatocellular necrosis (HP:0001404) | 2.29600719 |
82 | Ventricular tachycardia (HP:0004756) | 2.28299822 |
83 | Left ventricular hypertrophy (HP:0001712) | 2.27484841 |
84 | Foot dorsiflexor weakness (HP:0009027) | 2.26314310 |
85 | Dysmetria (HP:0001310) | 2.22357314 |
86 | Malignant hyperthermia (HP:0002047) | 2.21220184 |
87 | Acute encephalopathy (HP:0006846) | 2.20322670 |
88 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.19615486 |
89 | Dysdiadochokinesis (HP:0002075) | 2.18839561 |
90 | Failure to thrive in infancy (HP:0001531) | 2.17122685 |
91 | Abnormal eating behavior (HP:0100738) | 2.16261345 |
92 | Proximal amyotrophy (HP:0007126) | 2.15556030 |
93 | Gaze-evoked nystagmus (HP:0000640) | 2.13890560 |
94 | Increased CSF lactate (HP:0002490) | 2.13751455 |
95 | Ragged-red muscle fibers (HP:0003200) | 2.13245033 |
96 | Increased variability in muscle fiber diameter (HP:0003557) | 2.12830629 |
97 | Ventricular arrhythmia (HP:0004308) | 2.11988762 |
98 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.11626608 |
99 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.11626608 |
100 | Action tremor (HP:0002345) | 2.09882893 |
101 | Fetal akinesia sequence (HP:0001989) | 2.09842381 |
102 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.08448571 |
103 | Difficulty climbing stairs (HP:0003551) | 2.07394984 |
104 | * Poor eye contact (HP:0000817) | 2.06175415 |
105 | Neck muscle weakness (HP:0000467) | 2.05421114 |
106 | Shoulder girdle muscle weakness (HP:0003547) | 2.05113910 |
107 | Dysmetric saccades (HP:0000641) | 2.04135312 |
108 | Muscular dystrophy (HP:0003560) | 2.03036489 |
109 | Asymmetric septal hypertrophy (HP:0001670) | 2.01773478 |
110 | Polyphagia (HP:0002591) | 2.01697969 |
111 | Bulbar palsy (HP:0001283) | 2.00095931 |
112 | Increased serum pyruvate (HP:0003542) | 1.99829477 |
113 | Abnormality of glycolysis (HP:0004366) | 1.99829477 |
114 | Termporal pattern (HP:0011008) | 1.99544910 |
115 | Insidious onset (HP:0003587) | 1.99544910 |
116 | Lower limb amyotrophy (HP:0007210) | 1.98520216 |
117 | Weak cry (HP:0001612) | 1.98360288 |
118 | Palpitations (HP:0001962) | 1.97994813 |
119 | Progressive muscle weakness (HP:0003323) | 1.97976956 |
120 | Gowers sign (HP:0003391) | 1.97215390 |
121 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.96845076 |
122 | Slender build (HP:0001533) | 1.94471358 |
123 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.94259294 |
124 | Limb-girdle muscle weakness (HP:0003325) | 1.93653807 |
125 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.92839468 |
126 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.90768383 |
127 | Abnormality of alanine metabolism (HP:0010916) | 1.90768383 |
128 | Hyperalaninemia (HP:0003348) | 1.90768383 |
129 | Postural instability (HP:0002172) | 1.90557411 |
130 | Lower limb muscle weakness (HP:0007340) | 1.90367270 |
131 | Heart block (HP:0012722) | 1.89567776 |
132 | Spastic gait (HP:0002064) | 1.89257878 |
133 | Exercise intolerance (HP:0003546) | 1.88355967 |
134 | * Abnormal social behavior (HP:0012433) | 1.87866990 |
135 | * Impaired social interactions (HP:0000735) | 1.87866990 |
136 | Rapidly progressive (HP:0003678) | 1.86672128 |
137 | Hepatic necrosis (HP:0002605) | 1.86667118 |
138 | Agitation (HP:0000713) | 1.86642872 |
139 | Pelvic girdle muscle weakness (HP:0003749) | 1.82608882 |
140 | Spinal rigidity (HP:0003306) | 1.81483853 |
141 | Hip contracture (HP:0003273) | 1.81066578 |
142 | Atrioventricular block (HP:0001678) | 1.78232657 |
143 | Hyperkalemia (HP:0002153) | 1.75991036 |
144 | Steppage gait (HP:0003376) | 1.71631176 |
145 | Waddling gait (HP:0002515) | 1.70215453 |
146 | Fatigable weakness (HP:0003473) | 1.68261114 |
147 | Abnormality of the neuromuscular junction (HP:0003398) | 1.68261114 |
148 | Increased intramyocellular lipid droplets (HP:0012240) | 1.66336997 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 3.46839561 |
2 | PHKG2 | 3.30318725 |
3 | PHKG1 | 3.30318725 |
4 | OBSCN | 3.05129357 |
5 | MAP3K12 | 2.85147321 |
6 | MAP3K4 | 2.78701709 |
7 | EPHA4 | 2.78101473 |
8 | CASK | 2.54488640 |
9 | MAP3K9 | 2.38479487 |
10 | MAP2K7 | 2.26309747 |
11 | MARK1 | 2.20154108 |
12 | TTN | 2.13867175 |
13 | MINK1 | 2.12458871 |
14 | MAP2K4 | 1.94649461 |
15 | CDK19 | 1.89784097 |
16 | PAK6 | 1.75161392 |
17 | NTRK2 | 1.70534253 |
18 | RIPK4 | 1.65869468 |
19 | PINK1 | 1.59890473 |
20 | NME1 | 1.59537367 |
21 | LMTK2 | 1.52434916 |
22 | NEK1 | 1.47031817 |
23 | PDK3 | 1.43387274 |
24 | PDK4 | 1.43387274 |
25 | OXSR1 | 1.42028351 |
26 | UHMK1 | 1.33340871 |
27 | SIK3 | 1.32379082 |
28 | CDK5 | 1.28313167 |
29 | DAPK2 | 1.27268275 |
30 | PLK2 | 1.27109384 |
31 | GRK5 | 1.16211238 |
32 | DAPK1 | 1.14838509 |
33 | DMPK | 1.14082377 |
34 | CAMKK2 | 1.14070571 |
35 | MUSK | 1.13286956 |
36 | MAPKAPK3 | 1.13151873 |
37 | WNK3 | 1.13102898 |
38 | CAMK2A | 1.12952501 |
39 | KSR2 | 1.12783966 |
40 | MAPK13 | 1.12676438 |
41 | PRPF4B | 1.09997458 |
42 | FES | 1.05611269 |
43 | NTRK1 | 1.05499831 |
44 | MYLK | 1.03621906 |
45 | ERBB3 | 1.01725718 |
46 | KSR1 | 1.01314639 |
47 | CAMKK1 | 0.99381319 |
48 | GRK7 | 0.97940603 |
49 | CAMK2D | 0.97883373 |
50 | STK39 | 0.95686276 |
51 | PRKCG | 0.94547015 |
52 | ARAF | 0.94412875 |
53 | CAMK2B | 0.93056043 |
54 | PIK3CA | 0.90394469 |
55 | TNIK | 0.88998999 |
56 | SGK494 | 0.88337386 |
57 | SGK223 | 0.88337386 |
58 | MAPK12 | 0.84118649 |
59 | CCNB1 | 0.83638632 |
60 | CAMK4 | 0.83037797 |
61 | WNK4 | 0.82852761 |
62 | PRKAA1 | 0.82689846 |
63 | PAK3 | 0.82453704 |
64 | TRPM7 | 0.81485212 |
65 | PNCK | 0.78276162 |
66 | MAP2K3 | 0.75716187 |
67 | WNK1 | 0.75661111 |
68 | PRKCH | 0.73999702 |
69 | LIMK1 | 0.73955763 |
70 | CAMK1 | 0.73509936 |
71 | PRKD3 | 0.73432972 |
72 | CAMK2G | 0.72355182 |
73 | TNK2 | 0.72149921 |
74 | PRKCE | 0.71657245 |
75 | MAP3K7 | 0.71276414 |
76 | SIK2 | 0.70386526 |
77 | PRKAA2 | 0.69193374 |
78 | NEK9 | 0.69110260 |
79 | CDK18 | 0.68880882 |
80 | BCR | 0.67218831 |
81 | PKN1 | 0.66988131 |
82 | MAPK7 | 0.65295544 |
83 | PDK2 | 0.64985046 |
84 | STK38 | 0.63958407 |
85 | CDK14 | 0.62414940 |
86 | PRKG1 | 0.61696992 |
87 | CDK15 | 0.61675066 |
88 | ROCK2 | 0.60986432 |
89 | RET | 0.60462179 |
90 | MAP2K6 | 0.60018028 |
91 | PDPK1 | 0.59699831 |
92 | MAP3K5 | 0.59500881 |
93 | PIK3CG | 0.59463114 |
94 | PTK2B | 0.58975940 |
95 | MAPKAPK5 | 0.57569019 |
96 | PDK1 | 0.57491345 |
97 | SGK2 | 0.57249948 |
98 | SGK1 | 0.57248544 |
99 | MAP3K1 | 0.52530273 |
100 | MAP3K6 | 0.52047292 |
101 | CDK11A | 0.50262836 |
102 | AKT2 | 0.49795184 |
103 | LATS2 | 0.48770006 |
104 | MAP2K1 | 0.48111306 |
105 | STK11 | 0.46639237 |
106 | PRKACA | 0.45834374 |
107 | MAPK4 | 0.45604820 |
108 | AKT3 | 0.44361902 |
109 | MARK2 | 0.43719517 |
110 | MAPK10 | 0.43461959 |
111 | DAPK3 | 0.41810663 |
112 | RAF1 | 0.41773855 |
113 | SGK3 | 0.41555771 |
114 | TAOK1 | 0.41186544 |
115 | PRKACB | 0.40884721 |
116 | EEF2K | 0.40353562 |
117 | RPS6KA3 | 0.39911664 |
118 | MAP3K13 | 0.39862002 |
119 | ROCK1 | 0.38815257 |
120 | TYRO3 | 0.38067451 |
121 | SCYL2 | 0.37704866 |
122 | RPS6KB1 | 0.37605125 |
123 | CDC42BPA | 0.37229983 |
124 | PRKD1 | 0.33881134 |
125 | CSNK1G2 | 0.33718900 |
126 | MOS | 0.31258219 |
127 | STK38L | 0.29411292 |
128 | MAPK11 | 0.27142611 |
129 | RIPK1 | 0.26838364 |
130 | CSNK1G3 | 0.26640508 |
131 | PRKACG | 0.26244654 |
132 | BRAF | 0.25816629 |
133 | CSNK1G1 | 0.23526170 |
134 | DYRK1A | 0.23364996 |
135 | EPHA3 | 0.22740970 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.17369857 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.97257291 |
3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.72607520 |
4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.60597770 |
5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.49564505 |
6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.42450876 |
7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.38441040 |
8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.28604791 |
9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.21770533 |
10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.20760726 |
11 | Morphine addiction_Homo sapiens_hsa05032 | 2.19576406 |
12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.04671820 |
13 | Long-term potentiation_Homo sapiens_hsa04720 | 2.04159009 |
14 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.97712733 |
15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.97073988 |
16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.93513383 |
17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.90773564 |
18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.89375961 |
19 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.87370799 |
20 | Insulin secretion_Homo sapiens_hsa04911 | 1.85188205 |
21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.82455218 |
22 | Salivary secretion_Homo sapiens_hsa04970 | 1.71920497 |
23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.70153509 |
24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.66385688 |
25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.65471931 |
26 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.63803460 |
27 | Taste transduction_Homo sapiens_hsa04742 | 1.62515906 |
28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.58983544 |
29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.53750807 |
30 | Renin secretion_Homo sapiens_hsa04924 | 1.50289619 |
31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49620039 |
32 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.45174101 |
33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39947436 |
34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.38102811 |
35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.36015026 |
36 | Long-term depression_Homo sapiens_hsa04730 | 1.33593406 |
37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.26568601 |
38 | Cocaine addiction_Homo sapiens_hsa05030 | 1.25209208 |
39 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.17834245 |
40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.13044879 |
41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12823891 |
42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08963123 |
43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.04311529 |
44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04197986 |
45 | Gap junction_Homo sapiens_hsa04540 | 1.04061428 |
46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.02904735 |
47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02095744 |
48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.98641742 |
49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98138800 |
50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.96197042 |
51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94961217 |
52 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.94010750 |
53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92780663 |
54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92193721 |
55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89543080 |
56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88093258 |
57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.86237625 |
58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85647434 |
59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84459516 |
60 | Phototransduction_Homo sapiens_hsa04744 | 0.83562521 |
61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.80394782 |
62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73465912 |
63 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72670492 |
64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72206804 |
65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71411913 |
66 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71052650 |
67 | Insulin resistance_Homo sapiens_hsa04931 | 0.70902120 |
68 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.68794296 |
69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67626514 |
70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67622517 |
71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65628707 |
72 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.65403524 |
73 | Axon guidance_Homo sapiens_hsa04360 | 0.64774770 |
74 | Tight junction_Homo sapiens_hsa04530 | 0.63066807 |
75 | Glioma_Homo sapiens_hsa05214 | 0.61322506 |
76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61007428 |
77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59919944 |
78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59281584 |
79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55148086 |
80 | Melanogenesis_Homo sapiens_hsa04916 | 0.54446032 |
81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.53648877 |
82 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.52002131 |
83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50831748 |
84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49769364 |
85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.49282063 |
86 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48547624 |
87 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48434358 |
88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45943653 |
89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44555330 |
90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44534516 |
91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44110597 |
92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43585461 |
93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43446490 |
94 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43195286 |
95 | Phagosome_Homo sapiens_hsa04145 | 0.42832033 |
96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42633953 |
97 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.42252343 |
98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41544985 |
99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41331800 |
100 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40466997 |
101 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.38495970 |
102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38459794 |
103 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.37966291 |
104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37858103 |
105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37654893 |
106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36462296 |
107 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.36387800 |
108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.36275753 |
109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35418050 |
110 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34245655 |
111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33415022 |
112 | Focal adhesion_Homo sapiens_hsa04510 | 0.33200556 |
113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33014626 |
114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31628255 |
115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29456482 |
116 | Endocytosis_Homo sapiens_hsa04144 | 0.29435593 |
117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28382921 |
118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27491889 |
119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26594454 |
120 | Purine metabolism_Homo sapiens_hsa00230 | 0.24838984 |
121 | Viral myocarditis_Homo sapiens_hsa05416 | 0.23414248 |